Radiation Oncology/Therapy: Page 3

ASTRO: Short prostate SBRT reduces side effects, but not PSA levels

By Kate Madden Yee

Study findings offer new evidence to help guide treatment decisions for patients with localized prostate cancer, researchers said.

October 1, 2025

ASTRO: STAR has role in managing VT in cardiac patients

By Amerigo Allegretto

Stereotactic arrhythmia radiotherapy (STAR) is safe and effective for treating refractory VT compared to repeat catheter ablation.

October 1, 2025

ASTRO: Daily MRgRT recontouring improves prostate treatment outcomes

By Kate Madden Yee

Daily online adaptive recontouring is associated with clinically meaningful benefit in patient-reported quality of life measures.

September 30, 2025

ASTRO: Radiation therapy comparable to surgery for early-stage lung cancer

By Will Morton

At 10 years, overall survival was virtually identical between patients treated with radiation therapy versus surgery.

September 30, 2025

ASTRO: Proton therapy shows promise in breast cancer treatment

By Amerigo Allegretto

Proton radiation achieves similar health-related quality of life measures compared to photon radiation in breast cancer patients.

September 30, 2025

ASTRO: Trial suggests postoperative RT in high-risk bladder cancer

By Liz Carey

Moderate doses of radiation therapy (RT) after bladder removal surgery cut rates of new pelvic cancer, according to researchers.

September 30, 2025

ASTRO: Lu-177 PNT2002 added to SBRT delays prostate cancer progression

By Will Morton

Two cycles of lutetium-177 PNT2002 before stereotactic body radiation therapy (SBRT) significantly improved progression-free survival.

September 29, 2025

ASTRO: Contemporary IMRT comparable to proton therapy for throat cancer

By Liz Carey

Phase III U.K. TORPEdO trial investigated proton beam therapy for reducing long-term treatment-related toxicities.

September 29, 2025

ASTRO: Low-dose RT effective for treating knee osteoarthritis

By Amerigo Allegretto

Research presented at ASTRO 2025 showed the effectiveness of low-dose radiation therapy for treating knee osteoarthritis.

September 29, 2025

ASTRO: Genomic test predicts benefit of hormone therapy in prostate cancer

By Will Morton

Patients with a prostate tumor subtype known as luminal B had meaningful benefits from the addition of apalutamide to secondary radiotherapy.

September 29, 2025

ASTRO: Patient navigation key to mitigating RT treatment disparities

By Kate Madden Yee

"Patients are lost and need to be navigated," said presenter Christina Chapman, MD, of Baylor College of Medicine in Houston.

September 29, 2025

ASTRO: Radiotherapy offers opportunities beyond cancer treatment

By Kate Madden Yee

Radiotherapy isn't just for cancer treatment, according to talks at ASTRO 2025 in San Francisco.

September 28, 2025

Previous Page

Page 3 of 468

Next Page